A Phase I Trial of Inhaled Iloprost for the Prevention of Lung Cancer in Former Smokers
Phase of Trial: Phase I
Latest Information Update: 21 Dec 2018
At a glance
- Drugs Iloprost (Primary)
- Indications Lung cancer
- Focus Adverse reactions
- 14 May 2018 Planned number of patients changed from 61 to 50.
- 11 Oct 2017 Planned primary completion date changed from 1 Oct 2018 to 1 Feb 2019.
- 21 Sep 2016 Status changed from suspended to recruiting.